TCWP’s Ambev ABEV Stock Holding History

TCWP’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,978	Closed	-$9K	–	270
2022 Q1	$9K	Buy	+2,978	New	+$8.32K	﹤0.01%	902

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TCWP's ABEV Position: Q2 2022 in Review

TCWP sold out of Ambev (ABEV) in Q2 2022, closing a stake of 2,978 shares — an estimated $9K sold.

TCWP first reported a position in ABEV in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 289 funds tracked by Wall St. Rank hold ABEV as of Q2 2022.

TCWP reported no remaining Ambev position as of Q2 2022 after selling out during the quarter.
TCWP sold 2,978 Ambev shares in Q2 2022, an estimated $9K.
TCWP first reported a position in Ambev in Q1 2022 and held it in 1 quarter.
TCWP's Ambev position peaked at $9K in Q1 2022.
289 funds tracked by Wall St. Rank held Ambev as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.